tiprankstipranks
Advertisement
Advertisement

AXSM Stock Latest News

Axsome Therapeutics doses first patient in FOCUS-3 trial
The FlyAxsome Therapeutics doses first patient in FOCUS-3 trial
3d ago
AXSM
Axsome Therapeutics price target raised to $300 from $275 at TD Cowen
PremiumThe Fly
Axsome Therapeutics price target raised to $300 from $275 at TD Cowen
12d ago
AXSM
Axsome Shareholders Back Directors, Auditor and Executive Pay
PremiumCompany Announcements
Axsome Shareholders Back Directors, Auditor and Executive Pay
20d ago
8K
AXSM
Axsome adopts new executive severance and control plan
PremiumCompany Announcements
Axsome adopts new executive severance and control plan
20d ago
8K
AXSM
Axsome Therapeutics: Buy Rating Reiterated, $290 Price Target Unchanged on Extended SUNOSI Exclusivity and Late-Stage Pipeline Progress
PremiumRatings
Axsome Therapeutics: Buy Rating Reiterated, $290 Price Target Unchanged on Extended SUNOSI Exclusivity and Late-Stage Pipeline Progress
25d ago
AXSM
Analyst Reaffirms Buy on Axsome as Auvelity Peak Sales Outlook Surges Above $8B and Cash Runway Extends to Breakeven
PremiumRatingsAnalyst Reaffirms Buy on Axsome as Auvelity Peak Sales Outlook Surges Above $8B and Cash Runway Extends to Breakeven
25d ago
AXSM
Axsome secures long-term U.S. exclusivity for SUNOSI
Premium
Company Announcements
Axsome secures long-term U.S. exclusivity for SUNOSI
26d ago
8K
AXSM
Axsome Therapeutics announces settlement resolving Sunosi patent litigation
Premium
The Fly
Axsome Therapeutics announces settlement resolving Sunosi patent litigation
26d ago
AXSM
Truist’s Suvannavejh Lifts Auvelity Outlook and Sets $310 Price Target on Axsome Therapeutics Buy Rating
PremiumRatings
Truist’s Suvannavejh Lifts Auvelity Outlook and Sets $310 Price Target on Axsome Therapeutics Buy Rating
2M ago
AXSM
Axsome Therapeutics price target lowered to $280 from $281 at Deutsche Bank
PremiumThe Fly
Axsome Therapeutics price target lowered to $280 from $281 at Deutsche Bank
2M ago
AXSM
Axsome Therapeutics price target raised to $267 from $255 at Needham
PremiumThe Fly
Axsome Therapeutics price target raised to $267 from $255 at Needham
2M ago
AXSM
Axsome Therapeutics price target raised to $242 from $217 at Morgan Stanley
PremiumThe Fly
Axsome Therapeutics price target raised to $242 from $217 at Morgan Stanley
2M ago
AXSM
Axsome Therapeutics price target raised to $302 from $242 at RBC Capital
PremiumThe FlyAxsome Therapeutics price target raised to $302 from $242 at RBC Capital
2M ago
AXSM
Axsome Therapeutics price target raised to $310 from $228 at Mizuho
Premium
The Fly
Axsome Therapeutics price target raised to $310 from $228 at Mizuho
2M ago
AXSM
Axsome Therapeutics price target raised to $246 from $241 at Baird
Premium
The Fly
Axsome Therapeutics price target raised to $246 from $241 at Baird
2M ago
AXSM
Axsome Therapeutics price target raised to $290 from $270 at H.C. Wainwright
PremiumThe Fly
Axsome Therapeutics price target raised to $290 from $270 at H.C. Wainwright
2M ago
AXSM
Axsome Therapeutics price target raised to $276 from $239 at BofA
PremiumThe Fly
Axsome Therapeutics price target raised to $276 from $239 at BofA
2M ago
AXSM
Buy Rating Reiterated as Auvelity’s Expanded Alzheimer’s Opportunity Drives Upgraded $276 Price Target
PremiumRatings
Buy Rating Reiterated as Auvelity’s Expanded Alzheimer’s Opportunity Drives Upgraded $276 Price Target
2M ago
AXSM
Axsome Therapeutics Earnings Call Signals Aggressive Growth
PremiumCompany Announcements
Axsome Therapeutics Earnings Call Signals Aggressive Growth
2M ago
AXSM
Axsome Therapeutics price target raised to $280 from $250 at Oppenheimer
PremiumThe FlyAxsome Therapeutics price target raised to $280 from $250 at Oppenheimer
2M ago
AXSM
Axsome Therapeutics management to meet with Needham
Premium
The Fly
Axsome Therapeutics management to meet with Needham
2M ago
AXSM
Axsome Therapeutics management to meet with Piper Sandler
Premium
The Fly
Axsome Therapeutics management to meet with Piper Sandler
2M ago
AXSM

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >